Robert H. Pierce

1998–2024 年に発表

70
論文数
20,459
被引用数
54
h 指数
68
i10 指数

被引用数

Robert H. Pierce の年別被引用数1993 年: 被引用 1 件1995 年: 被引用 1 件1996 年: 被引用 1 件1999 年: 被引用 1 件2000 年: 被引用 7 件2001 年: 被引用 11 件2002 年: 被引用 17 件2003 年: 被引用 23 件2004 年: 被引用 23 件2005 年: 被引用 22 件2006 年: 被引用 33 件2007 年: 被引用 30 件2008 年: 被引用 36 件2009 年: 被引用 57 件2010 年: 被引用 83 件2011 年: 被引用 83 件2012 年: 被引用 81 件2013 年: 被引用 116 件2014 年: 被引用 113 件2015 年: 被引用 231 件2016 年: 被引用 330 件2017 年: 被引用 392 件2018 年: 被引用 450 件2019 年: 被引用 1,031 件2020 年: 被引用 1,404 件2021 年: 被引用 1,408 件2022 年: 被引用 1,153 件2023 年: 被引用 802 件2024 年: 被引用 1,048 件2025 年: 被引用 520 件2026 年: 被引用 21 件1994 年は被引用が無いため表示していません1997〜1998 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,788 件、この内訳の 27.4%中国: 引用元論文 2,124 件、この内訳の 15.3%イギリス: 引用元論文 733 件、この内訳の 5.3%ドイツ: 引用元論文 730 件、この内訳の 5.3%フランス: 引用元論文 582 件、この内訳の 4.2%イタリア: 引用元論文 574 件、この内訳の 4.1%日本: 引用元論文 463 件、この内訳の 3.3%オランダ: 引用元論文 429 件、この内訳の 3.1%オーストラリア: 引用元論文 422 件、この内訳の 3.1%カナダ: 引用元論文 382 件、この内訳の 2.8%スペイン: 引用元論文 350 件、この内訳の 2.5%スイス: 引用元論文 349 件、この内訳の 2.5%
0%27.4%その他 21.1%

分野

  • Medicine62.1%
  • Immunology and Microbiology19.3%
  • Biochemistry, Genetics and Molecular Biology13.5%
  • Engineering1.8%
  • Pharmacology, Toxicology and Pharmaceutics0.9%
  • Computer Science0.6%
  • その他1.8%

トピック

  • Cancer Immunotherapy and Biomarkers15.9%
  • Immunotherapy and Immune Responses9.2%
  • CAR-T cell therapy research7.2%
  • Immune Cell Function and Interaction6.1%
  • Immune cells in cancer3.8%
  • T-cell and B-cell Immunology1.9%
  • その他55.9%

共著者

全論文

検索で開く
  1. PD-1 blockade induces responses by inhibiting adaptive immune resistance

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2014 被引用: 6,699

  2. Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12

    著者: , , , , , , , , , , , , , , , , , , , , , , - Immunity 2018 被引用: 937

  3. Immunogenic Chemotherapy Enhances Recruitment of CAR-T Cells to Lung Tumors and Improves Antitumor Efficacy when Combined with Checkpoint Blockade

    著者: , , , , , , , , , , , , , , , , , , , - Cancer Cell 2020 被引用: 334

  4. Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Immunology Research 2017 被引用: 443

  5. Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frédérique Penault‐Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea L. Richardson, Yihong Wang, Ewa Chmielik, Jane Brock, Douglas B. Johnson, Justin M. Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternès, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra A. O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix‐Triki, Marc J. van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph A. Sparano, David L. Rimm, Torsten O. Nielsen, Zuzana Kos, Stephen M. Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard‐Gallo, Hugo M. Horlings, Leena Gandhi, André Moreira, Fred R. Hirsch, Maria Vittoria Dieci, María Urbanowicz, Iva Brčić, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer M. Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan Juco, Carsten Denkert, Jorge S. Reis‐Filho, Sherene Loi, Stephen B. Fox - Advances in Anatomic Pathology 2017 被引用: 799

  6. Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Simone M. Goldinger, Edward B. Garon, Robert H. Pierce, Adil Daud - Cancer Immunology Research 2017 被引用: 565

  7. Logic-Gated ROR1 Chimeric Antigen Receptor Expression Rescues T Cell-Mediated Toxicity to Normal Tissues and Enables Selective Tumor Targeting

    著者: , , , , , , , , , , - Cancer Cell 2019 被引用: 325

  8. Phase I Study of Pembrolizumab (MK-3475; Anti–PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors

    著者: , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2015 被引用: 794

  9. Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frédérique Penault‐Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea L. Richardson, Yihong Wang, Ewa Chmielik, Jane B. Brock, Douglas B. Johnson, Justin M. Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternès, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra A. O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix‐Triki, Marc J. van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph A. Sparano, David L. Rimm, Torsten O. Nielsen, Zuzana Kos, Stephen M. Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard‐Gallo, Hugo M. Horlings, Leena Gandhi, André L. Moreira, Fred R. Hirsch, Maria Vittoria Dieci, María Urbanowicz, Iva Brčić, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer M. Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan Juco, Carsten Denkert, Jorge S. Reis‐Filho, Sherene Loi, Stephen B. Fox - Advances in Anatomic Pathology 2017 被引用: 720

  10. IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells

    著者: , , , , , , , , , , , , , , , - Nature Medicine 2012 被引用: 1,041

  11. Mobilization of CD8+ T Cells via CXCR4 Blockade Facilitates PD-1 Checkpoint Therapy in Human Pancreatic Cancer

    著者: , , , , , , , , , , , , , , , - Clinical Cancer Research 2019 被引用: 227

  12. Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA

    著者: , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2018 被引用: 287

  13. Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC

    著者: , , , , , , , , , , , , , , , , , - JCI Insight 2019 被引用: 192

  14. Tumor immune profiling predicts response to anti–PD-1 therapy in human melanoma

    著者: , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2016 被引用: 527

  15. The Liver–Immunity Nexus and Cancer Immunotherapy

    著者: , , , , , - Clinical Cancer Research 2021 被引用: 115

  16. Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent Melanoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2020 被引用: 146

  17. Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Holbrook E. Kohrt, Martin A. Cheever, Youn H. Kim - Journal of Clinical Oncology 2019 被引用: 229

  18. Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial

    著者: , , , , , , , , , , , , , - Cancer Immunology Research 2019 被引用: 163

  19. Intratumoral delivery of tavokinogene telseplasmid yields systemic immune responses in metastatic melanoma patients

    著者: , , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2020 被引用: 135

  20. T-cell Localization, Activation, and Clonal Expansion in Human Pancreatic Ductal Adenocarcinoma

    著者: , , , , - Cancer Immunology Research 2017 被引用: 198

  21. Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Journal for ImmunoTherapy of Cancer 2020 被引用: 82

  22. Intratumoral Plasmid IL12 Electroporation Therapy in Patients with Advanced Melanoma Induces Systemic and Intratumoral T-cell Responses

    著者: , , , , , , , , , , , - Cancer Immunology Research 2019 被引用: 95

  23. Toll-Like Receptor 4 Agonist Injection With Concurrent Radiotherapy in Patients With Metastatic Soft Tissue Sarcoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2023 被引用: 27

  24. The Collagen Binding α1β1 Integrin VLA-1 Regulates CD8 T Cell-Mediated Immune Protection against Heterologous Influenza Infection

    著者: , , , , , , , , - Immunity 2004 被引用: 315